Vanguard Portfolio Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Vanguard Portfolio Management's ELV Position: Q2 2026 in Review
Vanguard Portfolio Management reduced its Elevance Health (ELV) stake by 2.2% in Q2 2026, selling an estimated $52.6M and leaving 6,214,356 shares worth $2.4B. The position accounts for 0.11% of the portfolio, ranked #196.
Vanguard Portfolio Management first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 1,513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Vanguard Portfolio Management held 6,214,356 shares of Elevance Health worth $2.4B as of Q2 2026.
- Vanguard Portfolio Management sold 141,721 Elevance Health shares in Q2 2026, an estimated $52.6M.
- Elevance Health made up 0.11% of Vanguard Portfolio Management's portfolio in Q2 2026, its #196 holding.
- Vanguard Portfolio Management first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
- 1,513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.